Wolverine Trading’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20,300
Closed -$4K 5262
2022
Q4
$4K Sell
20,300
-1,400
-6% -$419 ﹤0.01% 3842
2022
Q3
$9K Buy
+21,700
New +$14.8K ﹤0.01% 4459
2022
Q2
Sell
-13,700
Closed -$12K 6269
2022
Q1
$12K Buy
+13,700
New +$12.8K ﹤0.01% 5291
2021
Q4
Sell
-34,700
Closed -$87K 7419
2021
Q3
$87K Buy
34,700
+19,800
+133% +$54.9K ﹤0.01% 5841
2021
Q2
$45K Buy
+14,900
New +$51.9K ﹤0.01% 5617
2021
Q1
Sell
-34,900
Closed -$170K 6669
2020
Q4
$170K Sell
34,900
-7,900
-18% -$40.8K ﹤0.01% 4313
2020
Q3
$204K Buy
42,800
+16,100
+60% +$76.3K ﹤0.01% 3851
2020
Q2
$85K Buy
+26,700
New +$254K ﹤0.01% 4187

Other funds holding CEMI

Wolverine Trading's CEMI Position: Q1 2022 in Review

Wolverine Trading sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2022, closing a stake of 13,173 shares — an estimated $12.3K sold.

Wolverine Trading first reported a position in CEMI in Q3 2021 and held it in 2 quarters. The position peaked at $57K in Q3 2021. 36 funds tracked by Wall St. Rank hold CEMI as of Q1 2022.

  • Wolverine Trading reported no remaining Chembio diagnostics, Inc. position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 13,173 Chembio diagnostics, Inc. shares in Q1 2022, an estimated $12.3K.
  • Wolverine Trading first reported a position in Chembio diagnostics, Inc. in Q3 2021 and held it in 2 quarters.
  • Wolverine Trading's Chembio diagnostics, Inc. position peaked at $57K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.